StockMarketWire.com - PureTech Health affiliate Sonde Health has appointed David Liu as chief executive and a member of its board of directors.

The appointment follows the recently announced $16m Series A financing directed to advance Sonde's capability across multiple health conditions and device types, as well as its commercialisation activities.

Liu most recently served as president and chief operating officer at Quartet, a growth stage enterprise healthcare technology company that connects primary care physicians with mental health providers.

Edward Kliphuis, investment director at M Ventures and board director at Sonde Health, said, 'Sonde Health's vocal biomarker technology has the potential to fundamentally transform the way we monitor and manage our health and wellbeing.

'David's wealth of experience at the intersection of healthcare and technology along with his significant executive and entrepreneurial experience position him perfectly to take Sonde to the next stage of growth.'


At 9:50am: [LON:PRTC] PureTech Health Plc share price was -1.5p at 253.5p



Story provided by StockMarketWire.com